BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Diagnosis
74 results:

  • 1. [Clinicopathological features of intravascular large B-cell lymphoma and collision tumors of five cases].
    Liu J; Liu GZ; Xia L; Wang HY; Zhang XF; Liu H
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):22-28. PubMed ID: 38178742
    [No Abstract]    [Full Text] [Related]  

  • 2. Case Report: Complete pathological remission of human chorionic gonadotrophin-producing gallbladder carcinoma with multiple liver metastases after treatment with chemotherapy plus an immune checkpoint inhibitor.
    Wang Q; Mu Y; Ji S; Liu Y; Lou Y; Wei S; Dong X; Zhang B
    Front Immunol; 2023; 14():1173520. PubMed ID: 37841278
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Network Pharmacology-Based Identification of Key Pharmacological Mechanism of Shen-qi-di-huang Decoction Acting on Uremia.
    Zhang X; Chen XF; Chen WJ; Ding H; Zhang BX
    Altern Ther Health Med; 2024 Jan; 30(1):44-50. PubMed ID: 37773677
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy.
    Cui Z; Zou F; Wang R; Wang L; Cheng F; Wang L; Pan R; Guan X; Zheng N; Wang W
    World J Surg Oncol; 2023 Sep; 21(1):309. PubMed ID: 37759234
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hepatic Angiosarcomas With Sinusoidal Growth Patterns.
    Soon GST; Chen ZE; Wu TT; Torbenson MS; Yasir S
    Am J Surg Pathol; 2023 Sep; 47(9):1045-1051. PubMed ID: 37357916
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MESP1-knockdown inhibits the proliferation and epithelial mesenchymal transition of hepatocellular carcinoma and enhances the tumor-suppressive effect of 5-fluorouracil.
    Ji S; Xu M; Cai C; He X
    Biochem Biophys Res Commun; 2023 Aug; 670():1-11. PubMed ID: 37271034
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. UBE2K promotes the malignant progression of hepatocellular carcinoma by regulating c-myc.
    Lei X; Hu X; Lu Q; Yao Y; Sun W; Ma Q; Huang D; Xu Q
    Biochem Biophys Res Commun; 2023 Jan; 638():210-218. PubMed ID: 36481361
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Hematological and neurological expressed 1 (HN1) activates c-myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of c-myc in hepatocellular carcinoma.
    Feng J; Liu Y; Fang T; Zhu J; Wang G; Li J
    Cell Biol Int; 2023 Mar; 47(3):560-572. PubMed ID: 36403281
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Desmocollin-2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma via the ERK/c-myc signaling pathway.
    He B; Guo L; Hu Y; Huang H; Wan L; Xu K; Wang F; Wen Z
    Aging (Albany NY); 2022 Nov; 14(21):8805-8817. PubMed ID: 36367775
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Primary hepatic lymphoma- A diagnostic dilemma.
    Reddy P; Vernekar SS; Sneha P
    Indian J Pathol Microbiol; 2022; 65(4):925-927. PubMed ID: 36308209
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer.
    Bray AW; Duan R; Malalur P; Drusbosky LM; Gourdin TS; Hill EG; Lilly MB
    Prostate; 2022 Sep; 82(13):1264-1272. PubMed ID: 35766303
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Direct Conversion of Human Endothelial Cells Into liver cancer-Forming Cells Using Nonintegrative Episomal Vectors.
    Goya T; Horisawa K; Udono M; Ohkawa Y; Ogawa Y; Sekiya S; Suzuki A
    Hepatol Commun; 2022 Jul; 6(7):1725-1740. PubMed ID: 35220676
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. 33-kDa ANXA3 isoform contributes to hepatocarcinogenesis
    Guo C; Li N; Dong C; Wang L; Li Z; Liu Q; Ma Q; Greenaway FT; Tian Y; Hao L; Liu S; Sun MZ
    J Adv Res; 2021 May; 30():85-102. PubMed ID: 34026289
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway.
    Sun L; Liu S; Wang X; Zheng X; Chen Y; Shen H
    J Transl Med; 2021 May; 19(1):216. PubMed ID: 34016142
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo-related genes in hepatocellular carcinoma.
    Pan Q; Qin F; Yuan H; He B; Yang N; Zhang Y; Ren H; Zeng Y
    Cancer Med; 2021 May; 10(9):3139-3152. PubMed ID: 33818013
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy tools.
    Gerratana L; Davis AA; Polano M; Zhang Q; Shah AN; Lin C; Basile D; Toffoli G; Wehbe F; Puglisi F; Behdad A; Platanias LC; Gradishar WJ; Cristofanilli M
    Eur J Cancer; 2021 Jan; 143():147-157. PubMed ID: 33307492
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion.
    Li R; Deng Y; Liang J; Hu Z; Li X; Liu H; Wang G; Fu B; Zhang T; Zhang Q; Yang Y; Chen G; Liu W
    Cell Oncol (Dordr); 2021 Apr; 44(2):279-295. PubMed ID: 33034848
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Aberrant NSUN2-mediated m
    Sun Z; Xue S; Zhang M; Xu H; Hu X; Chen S; Liu Y; Guo M; Cui H
    Oncogene; 2020 Nov; 39(45):6906-6919. PubMed ID: 32978516
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. ASTN1 is associated with immune infiltrates in hepatocellular carcinoma, and inhibits the migratory and invasive capacity of liver cancer via the Wnt/β‑catenin signaling pathway.
    Chen QF; Shi F; Huang T; Huang C; Shen L; Wu P; Li W
    Oncol Rep; 2020 Oct; 44(4):1425-1440. PubMed ID: 32945491
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. MPC1 Deficiency Promotes CRC liver Metastasis via Facilitating Nuclear Translocation of
    Tian GA; Xu CJ; Zhou KX; Zhang ZG; Gu JR; Zhang XL; Wang YH
    J Immunol Res; 2020; 2020():8340329. PubMed ID: 32851100
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.